Table 1.

Characteristics the 176 patients with early‐stage HCC

Characteristics	Value
Age, years	74 (44–90)
Duration of follow‐up, months	26 (7.4–35)
Sex, [n (%)]
Male	103 (59)
Female	73 (41)
Clinical and laboratory data
AFP, median (range), ng/mL	11.1 (2–11000)
AFP‐L3 index, median (range), %	4.5 (0.5–83.6)
DCP, median (range), mAU/mL	21 (10–3790)
Child–Pugh class [n (%)]
A	167 (95)
B	9 (5)
Serum albumin, median (range), g/dL	3.7 (2.3–5.1)
Serum total bilirubin, median (range), mg/dL	0.8 (0.2–8)
Prothrombin time, median (range), %	91.4 (47.2–120)
Pathology
Maximum HCC diameter, mm, [n (%)]
<20 mm	128 (73)
≥20 mm	48 (27)
Number of HCC nodules, [n (%)]
Single	125 (71)
Multiple	51 (29)
Lymph node involvement (%)	0
Metastasis (%)	0
Treatment curse
Naïve	44 (25)
Recurrent	132 (75)
Major associated liver diseases, [n (%)]
HBV	12 (6.8)
HCV	139 (79)
Alcohol	11 (6.3)
NASH	16 (9.1)
unknown (%)	3 (1.7)

DCP, des‐gamma‐carboxy prothrombin.